epithalon w tabletkach — 3mg Capsules (30 Count) | Longevity Bioregulator Epithalon (40mg vials) - Peptide

The compound exists in a legal gray zone as a research chemical legal to possess, unlawful to sell as a therapeutic product

EGFR and c-MET have in common similar downstream pathways: MAPK (RAS/Rapidly accelerating fibrosarcoma (RAF)/ MAP kinase kinases (MEK)/ERK) and PI3K/AKT/mechanistic target of rapamycin (mTOR)

CNS Drugs 2017;31:1057-82

Drug interactions have not been extensively studied, warranting caution when combined with immunomodulatory or anticoagulant medications

The c-MET receptor tyrosine kinase is overexpressed in H69 cells and is inducible by exogenous HGF, resulting in induction of tyrosine phosphorylation at the major autophosphorylation sites pY1230/1234/1235 in the catalytic kinase domain, and also the pY1003 site in the juxtamembrane domain of c-MET (Figure 1)